TP53 and endometrial cancer: The Cancer Genome Atlas (TCGA) in 2013 identified four distinct molecular subtypes of endometrial cancer: POLE ultra-mutated, microsatellite instability-high (MSI-H), copy number-low [also referred to as no specific molecular profile (NSMP)], and copy number-high (p53-abnormal).